370716333	370716333	CD	B-NP	O
|	|	NN	I-NP	O
AMC	AMC	NN	I-NP	O
|	|	NN	I-NP	O
59702453	59702453	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7387931	7387931	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2006	10/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2006	8/13/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/4/2006	3/4/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ROGOL	ROGOL	NNP	B-NP	O
,	,	,	O	O
ANGELO	ANGELO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
837-62-24-5	837-62-24-5	CD	I-NP	O
Moines	Moines	NNP	I-NP	O
Landent	Landent	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ONC	ONC	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/19/06	10/19/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HOCKLEY	HOCKLEY	NNP	B-NP	O
,	,	,	O	O
DONNY	DONNY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ALBUTEROL	ALBUTEROL	NN	I-NP	I-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Wheezing	Wheezing	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
IBUPROFEN	IBUPROFEN	NN	I-NP	O
600	600	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
LACTULOSE	LACTULOSE	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q4H	Q4H	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
oversedated	oversedate	VBN	B-VP	O
,	,	,	O	O
RR	RR	NN	B-NP	O
<	<	SYM	B-NP	O
10	10	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
may	may	MD	B-VP	O
refuse	refuse	VB	I-VP	O
SENNA	SENNA	NN	B-NP	B-protein
LIQUID	LIQUID	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
TSP	TSP	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
HS	HS	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
HS	HS	NN	I-NP	I-protein
ZOLOFT	ZOLOFT	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SERTRALINE	SERTRALINE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/06	9/13/06	CD	B-NP	O
by	by	IN	B-PP	O
ORLANDER	ORLANDER	NNP	B-NP	O
,	,	,	O	O
DEANDRE	DEANDRE	NNP	B-NP	O
L	L	NNP	I-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEODON	GEODON	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
744726993	744726993	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SERTRALINE	SERTRALINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
COMPAZINE	COMPAZINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Nausea	Nausea	NNP	I-NP	O
LOVENOX	LOVENOX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FLOVENT	FLOVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
PROPIONATE	PROPIONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
110	110	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
June	June	NNP	I-NP	O
SEROQUEL	SEROQUEL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QUETIAPINE	QUETIAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
June	June	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/13/06	9/13/06	CD	B-NP	O
by	by	IN	B-PP	O
HIRD	HIRD	NNP	B-NP	O
,	,	,	O	O
JEAN	JEAN	NNP	B-NP	O
T	T	NNP	I-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEODON	GEODON	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
744726993	744726993	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
QUETIAPINE	QUETIAPINE	NNP	B-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
&	&	CC	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
NIFEDIPINE	NIFEDIPINE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NIFEDIPINE	NIFEDIPINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SL	SL	NNP	I-NP	O
...	...	:	O	B-DNA
-RRB-	-RRB-	NNP	B-NP	I-DNA
30	30	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
June	June	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

AVANDIA	AVANDIA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ROSIGLITAZONE	ROSIGLITAZONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GEODON	GEODON	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
June	June	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/13/06	9/13/06	CD	B-NP	O
by	by	IN	B-PP	O
MAUS	MAUS	NNP	B-NP	O
,	,	,	O	O
ERICK	ERICK	NNP	B-NP	O
L	L	NNP	I-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SERTRALINE	SERTRALINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
QUETIAPINE	QUETIAPINE	NNP	B-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
&	&	CC	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
ARANESP	ARANESP	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DARBEPOETIN	DARBEPOETIN	NNP	I-NP	O
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Q3WEEKS	Q3WEEKS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
ordering	order	VBG	B-VP	O
:	:	:	O	O
Oncology	Oncology	NNP	B-NP	O
-	-	HYPH	B-NP	O
Chemotherapy	Chemotherapy	NNP	I-NP	O
Induced	Induced	NNP	I-NP	O
Anemia	Anemia	NNP	I-NP	O
Last	Last	JJ	I-NP	O
known	know	VBN	I-NP	O
Hgb	Hgb	NN	I-NP	B-protein
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
order	order	NN	B-NP	O
:	:	:	O	O
9.1	9.1	CD	B-NP	O
g/dL	g/dL	NN	I-NP	O
on	on	IN	B-PP	O
10/14/06	10/14/06	CD	B-NP	O
at	at	IN	B-PP	O
SWMC	SWMC	NN	B-NP	O
Diagnosis	Diagnosis	NN	I-NP	O
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
in	in	IN	B-PP	O
Neoplastic	Neoplastic	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
285.22	285.22	CD	I-NP	O
Treatment	Treatment	NN	I-NP	O
Cycle	Cycle	NN	I-NP	O
:	:	:	O	O
Maintenance	Maintenance	NNP	B-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Tobias	Tobias	NNP	I-NP	O
Leitz	Leitz	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ollie	Ollie	NNP	I-NP	O
Stamnos	Stamnos	NNP	I-NP	O
11/17/06	11/17/06	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Shayne	Shayne	NNP	I-NP	O
Stromquist	Stromquist	NNP	I-NP	O
8/25/06	8/25/06	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
iddm	iddm	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
asthma	asthma	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
arthritis	arthritis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
ccy	ccy	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
S/P	S/P	NN	I-NP	I-protein
cholecystectomy	cholecystectomy	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
metastatic	metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
ca	ca	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
h/o	h/o	NN	I-NP	O
widely	widely	RB	B-NP	O
metastatic	metastatic	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
with	with	IN	B-PP	O
metastasis	metastasis	NN	B-NP	O
to	to	TO	B-VP	O
brain	brain	VB	I-VP	O
currently	currently	RB	B-ADVP	O
undergoing	undergo	VBG	B-VP	O
whole-brain	whole-brain	JJ	B-NP	O
XRT	XRT	NN	I-NP	O
,	,	,	O	O
bone	bone	NN	B-NP	O
,	,	,	O	O
lung	lung	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mediastinum	mediastinum	NN	B-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
ribs	rib	NNS	I-NP	O
,	,	,	O	O
p/w	p/w	NN	B-VP	O
to	to	TO	B-PP	O
ED	ED	VBN	B-VP	O
yesterday	yesterday	NN	B-NP	O
c/o	c/o	NN	I-NP	O
of	of	IN	B-PP	O
rib	rib	NN	B-NP	O
pain	pain	NN	I-NP	O
upon	upon	IN	B-PP	O
lifting	lift	VBG	B-VP	O
laundry	laundry	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
is	be	VBZ	B-VP	O
pleuritic	pleuritic	JJ	B-ADJP	O
and	and	CC	O	O
worsens	worsen	NNS	B-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
.	.	.	O	O

Got	Got	RB	B-ADVP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
and	and	CC	I-NP	O
codeine	codeine	NN	I-NP	O
.	.	.	O	O

PECT	PECT	NN	B-NP	O
initially	initially	RB	B-ADVP	O
read	read	VBD	B-VP	O
as	as	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	O
oncologist	oncologist	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
today	today	NN	B-NP	O
,	,	,	O	O
PECT	PECT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
this	this	DT	B-NP	O
am	am	NN	I-NP	O
as	as	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
although	although	IN	B-SBAR	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
in	in	IN	B-PP	O
RLL	RLL	NN	B-NP	B-cell_line
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
intermittent	intermittent	JJ	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
paresthesias	paresthesia	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
PECT	PECT	NN	B-NP	O
was	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
leg	leg	NN	I-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
back	back	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
as	as	IN	B-PP	O
above	above	IN	B-PP	O
;	;	:	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
constipation	constipation	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
BM	BM	NN	B-NP	O
since	since	IN	B-PP	O
10/17/06	10/17/06	CD	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAM	EXAM	NNP	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-DNA
97.7	97.7	CD	I-NP	I-DNA
,	,	,	O	O
P	P	NN	B-NP	B-protein
86	86	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
137/80	137/80	CD	I-NP	O
,	,	,	O	O
R	R	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	B-protein
98	98	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
2L	2L	NN	I-NP	I-protein
,	,	,	O	O
Wt	Wt	NN	B-NP	O
100	100	CD	I-NP	O
kg	kg	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
Morbidly	Morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
drowsy	drowsy	JJ	I-NP	O
s/p	s/p	NN	I-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
oriented	orient	VBN	B-VP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
NCAT	NCAT	NN	B-NP	B-protein
,	,	,	O	O
MMM	MMM	NN	B-NP	B-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
CTAB	CTAB	NN	I-NP	B-protein
.	.	.	O	O

R	R	NN	B-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
bony	bony	NN	I-NP	O
TTP	TTP	NN	I-NP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
:	:	:	O	O
Morbidly	Morbidly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
.	.	.	O	O

BS	BS	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
.	.	.	O	O

NTND	NTND	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

EXT	EXT	NN	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
B	B	NN	I-NP	O
BR/DP	BR/DP	NN	I-NP	O
.	.	.	O	O

Tr	Tr	NN	B-NP	B-protein
non-pitting	non-pitting	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
EKG	EKG	NN	I-NP	B-protein
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
RV	RV	NN	I-NP	O
strain	strain	NN	I-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST/TW	ST/TW	NN	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
PECT	PECT	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
PE	PE	NN	B-NP	O
-	-	HYPH	O	O
Anticoagulation	Anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
,	,	,	O	O
anti-factor	anti-factor	JJ	B-NP	O
Xa	Xa	NN	I-NP	O
level	level	NN	I-NP	O
reasonably	reasonably	RB	B-ADVP	O
in	in	IN	B-PP	O
range	range	NN	B-NP	O
at	at	IN	B-PP	O
1.03	1.03	CD	B-NP	O
.	.	.	O	O

Avoided	Avoid	VBN	B-NP	O
coumadin	coumadin	NN	I-NP	O
as	as	IN	B-PP	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
brain	brain	NN	B-NP	O
metastasis	metastasis	NN	I-NP	O
undergoing	undergo	VBG	B-VP	O
XRT	XRT	NN	B-NP	B-DNA
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
iron	iron	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Aranesp	Aranesp	NN	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	B-cell_type
ONC	ONC	NN	I-NP	I-cell_type
:	:	:	O	O
Metastatic	Metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
defer	defer	VB	I-VP	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	O
oncology	oncology	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
regimen	regimen	NN	I-NP	O
;	;	:	O	O
giving	give	VBG	B-VP	O
aranesp	aranesp	NN	B-NP	O
,	,	,	O	O
zometa	zometa	NN	B-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
XRT	XRT	NNP	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
ISCHEMIA	ISCHEMIA	NN	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
cont	cont	VBP	B-VP	O
ASA	ASA	NNP	B-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
HTN	HTN	NN	I-NP	B-protein
,	,	,	O	O
cont	cont	NN	B-NP	O
nifedipine	nifedipine	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
RESP	RESP	NN	I-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
-	-	HYPH	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	O
,	,	,	O	O
guaifenesin	guaifenesin	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	B-protein
ENDO	ENDO	NN	I-NP	I-protein
:	:	:	O	O
DM	DM	NN	B-NP	O
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
avandia	avandia	NN	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
lipitor	lipitor	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Morbid	Morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
-	-	HYPH	B-NP	O
nutrition	nutrition	NN	I-NP	O
consulted	consult	VBN	B-VP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
PSYCH/PAIN	PSYCH/PAIN	NN	I-NP	B-protein
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
geodon	geodon	NN	I-NP	O
,	,	,	O	O
seroquel	seroquel	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
regimen	regimen	NN	I-NP	O
per	per	IN	B-PP	O
primary	primary	JJ	B-NP	O
oncologist	oncologist	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
PPX	PPX	NN	B-NP	B-protein
:	:	SYM	O	O
Treatment	Treatment	NN	B-NP	O
dose	dose	NN	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
hospitalized	hospitalize	VBN	I-VP	O
for	for	IN	B-PP	O
starting	start	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

please	please	VB	B-INTJ	O
keep	keep	VB	B-VP	O
your	your	PRP$	B-NP	O
appointments	appointment	NNS	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

please	please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
MD	MD	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	I-VP	O
pain	pain	NN	B-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
cont	cont	VB	B-VP	O
lovenox	lovenox	NN	B-NP	O
keep	keep	NN	I-NP	O
f/u	f/u	NN	I-NP	O
appts	appt	VBZ	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BARILE	BARILE	NNP	B-NP	O
,	,	,	O	O
GINO	GINO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OG82	OG82	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/19/06	10/19/06	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

